analyse serial PSA levels after radical treatment using the same assay technique
biopsy of the prostatic bed should not be performed in men with prostate cancer who have had a radical prostatectomy
biopsy of the prostate after radiotherapy should only be performed in men with prostate cancer who are being considered for local salvage therapy in the context of a clinical trial
for men with evidence of biochemical relapse following radical treatment and who are considering radical salvage therapy:
routine MRI scanning should not be performed prior to salvage radiotherapy in men with prostate cancer
an isotope bone scan should be performed if symptoms or PSA trends are suggestive of metastases
biochemical relapse (a rising PSA) alone should not necessarily prompt an immediate change in treatment
biochemical relapse should trigger an estimate of PSA doubling time, based on a minimum of 3 measurements over at least a 6 month period
men with biochemical relapse after radical prostatectomy, with no known metastases, should be offered radical radiotherapy to the prostatic bed
men with biochemical relapse should be considered for entry to appropriate clinical trials
hormonal therapy is not routinely recommended for men with prostate cancer who have a biochemical relapse unless they have:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.